Use of induced pluripotent stem cell derived neurons engineered to express BDNF for modulation of stressor related pathology

Frontiers in Cellular Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Liu, Gele ^a   Rustom, Nazneen ^a   Litteljohn, Darcy ^a   Bobyn, Jessica ^a   Rudyk, Chris ^a   Anisman, Hymie ^a   Hayley, Shawn ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

BDNF; Depression; Neurogenesis; Stem cell; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; CORTICOSTERONE; DOPAMINE; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOPAMINERGIC NERVE CELL; FIBROBLAST; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; MOUSE; NERVE TRANSPLANTATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

EID: 84907974645     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00316     Document Type: Article

References (40)

1. Ahlenius, H., Devaraju K., Monni E., Oki K., Wattananit S., Darsalia V., et al. (2012). Adaptor protein LNK is a negative regulator of brain neural stem cell proliferation after stroke. J. Neurosci. 32, 5151–5164. doi:10.1523/JNEUROSCI.0474-12.2012
2. Andreasen, N. C., Nopoulos P., Magnotta V., Pierson R., Ziebell S., and Ho B. C. (2011). Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol. Psychiatry 70, 672–679. doi:10.1016/j.biopsych.2011.05.017
3. Anisman, H., Merali Z., and Hayley S. (2008). Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog. Neurobiol. 85, 1–74. doi:10.1016/j.pneurobio.2008.01.004
4. Autry, A. E., and Monteggia L. M. (2012). Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64, 238–258. doi:10.1124/pr.111.005108
5. Bielau, H., Brisch R., Gos T., Dobrowolny H., Baumann B., Mawrin C., et al. (2013). Volumetric analysis of the hypothalamus, amygdala and hippocampus in non-suicidal and suicidal mood disorder patients – a post-mortem study. CNS Neurol. Disord. Drug Targets 12, 914–920. doi:10.2174/18715273113129990092
6. Breton, A., Sharma R., Diaz A. C., Parham A. G., Graham A., Neil C., et al. (2013). Derivation and characterization of induced pluripotent stem cells from equine fibroblasts. Stem Cells Dev. 22, 611–621. doi:10.1089/scd.2012.0052
7. Faiz, M., and Nagy A. (2013). Induced pluripotent stem cells and disorders of the nervous system: progress, problems, and prospects. Neuroscientist doi:10.1177/1073858413493148 [Epub ahead of print].
8. Gibb, J., Hayley S., Poulter M. O., and Anisman H. (2011). Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity. Brain Behav. Immun. 25, 468–482. doi:10.1016/j.bbi.2010.11.008
9. Goings, G. E., Goings G. E., Greisman A., James R. E., Abram L. K., Begolka W. S., et al. (2008). Hematopoietic cell activation in the subventricular zone after Theiler’s virus infection. J. Neuroinflammation 5:44. doi:10.1186/1742-2094-5-44
10. Golden, S. A., Covington H. E., Berton O., and Russo S. J. (2011). A standardized protocol for repeated social defeat stress in mice. Nat. Protoc. 6, 1183–1191. doi:10.1038/nprot.2011.361
11. Greisen, M. H., Altar C. A., Bolwig T. G., Whitehead R., and Wörtwein G. (2005). Increased adult hippocampal brain-derived neurotrophic factor and normal levels of neurogenesis in maternal separation rats. J. Neurosci. Res. 79, 772–778. doi:10.1002/jnr.20418
12. Hasbi, A., Fan T., Alijaniaram M., Nguyen T., Perreault M. L., O’Dowd B. F., et al. (2009). Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc. Natl. Acad. Sci. U.S.A. 106, 21377–21382. doi:10.1073/pnas.0903676106
13. Hayley, S. (2011). Toward an anti-inflammatory strategy for depression. Front. Behav. Neurosci. 5:19. doi:10.3389/fnbeh.2011.00019
14. Hayley, S., and Litteljohn D. (2013). Neuroplasticity and the next wave of antidepressant strategies. Front. Cell. Neurosci. 7:218. doi:10.3389/fncel.2013.00218
15. Kaji, K., Norrby K., Paca A., Mileikovsky M., Mohseni P., and Woltjen K. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771–775. doi:10.1038/nature07864
16. Kim, J. H., Lee J. E., Kim S. U., and Cho K. G. (2010). Stereological analysis on migration of human neural stem cells of rats bearing glioma. Neurosurgery 66, 333–342. doi:10.1227/01.NEU.0000363720.07070.A8
17. Kroes, M. C., Rugg M. D., Whalley M. G., and Brewin C. R. (2011). Structural brain abnormalities common to posttraumatic stress disorder and depression. J. Psychiatry Neurosci. 36, 256–265. doi:10.1503/jpn.100077
18. Lee, M. M., Reif A., and Schmitt A. G. (2013). Major depression: a role for hippocampal neurogenesis? Curr. Top. Behav. Neurosci. 14, 153–179. doi:10.1007/7854_2012_226
19. Makar, T. K., Bever C. T., Singh I. S., Royal W., Sahu S. N., Sura T. P., et al. (2009). Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 210, 40–51. doi:10.1016/j.jneuroim.2009.02.017
20. Müller, F. J., Snyder E. Y., and Loring J. F. (2006). Gene therapy: can neural stem cells deliver? Nat. Rev. Neurosci. 7, 75–84. doi:10.1038/nrn1829
21. Na, K. S., Jung H. Y., and Kim Y. K. (2014). The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 48, 277–286. doi:10.1016/j.pnpbp.2012.10.022
22. Nagahara, A. H., and Tuszynski M. H. (2011). Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov. 10, 209–219. doi:10.1038/nrd3366
23. Niwa, H., Yamamura K., and Miyazaki J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193–199. doi:10.1016/0378-1119(91)90434-D
24. Nomura, T., Honmou O., Harada K., Houkin K., Hamada H., and Kocsis J. D. (2005). I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136, 161–169. doi:10.1016/j.neuroscience.2005.06.062
25. Pilakka-Kanthikeel, S., Atluri V. S., Sagar V., Saxena S. K., and Nair M. (2013). Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study. PLoS ONE 8:e62241. doi:10.1371/journal.pone.0062241
26. Saarelainen, T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. (2003). Activation of the TrkB neurotrophin receptor is induced by antide-pressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23, 349–357.
27. Schmidt, H. D., and Duman R. S. (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav. Pharmacol. 18, 391–418. doi:10.1097/FBP.0b013e3282ee2aa8
28. Schmidt, H. D., and Duman R. S. (2010). Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychophar-macology 35, 2378–2391. doi:10.1038/npp.2010.114
29. Seguin, J. A., Brennan J., Mangano E., and Hayley S. (2009). Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychitr. Dis. Treat. 5, 5–14.
30. Sheline, Y. I., Disabato B. M., Hranilovich J., Morris C., D’Angelo G., Pieper C., et al. (2012). Treatment course with antidepressant therapy in late-life depression. Am. J. Psychiatry 169, 1185–1193. doi:10.1176/appi.ajp.2012.12010122
31. Szymczak, A. L., Workman C. J., Wang Y., Vignali K. M., Dilioglou S., Vanin E. F., et al. (2004). Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589–594. doi:10.1038/nbt957
32. Tanti, A., and Belzung C. (2013). Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific? Neuroscience 252, 234–252. doi:10.1016/j.neuroscience.2013.08.017
33. Tfilin, M., Sudai E., Merenlender A., Gispan I., Yadid G., and Turge-man G. (2010). Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol. Psychiatry 15, 1164–1175. doi:10.1038/mp.2009.110
34. Vaccarino, F. M., Stevens H. E., Kocabas A., Palejev D., Szekely A., Grigorenko E. L., et al. (2011). Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders. Neuropharmacology 60, 1355–1363. doi:10.1016/j.neuropharm.2011.02.021
35. van Eijndhoven, P., van Wingen G., van Oijen K., Rijpkema M., Goraj B., Jan Verkes R., et al. (2009). Amygdala volume marks the acute state in the early course of depression. Biol. Psychiatry 65, 812–818. doi:10.1016/j.biopsych.2008.10.027
36. Vassilopoulou, K., Papathanasiou M., Michopoulos I., Boufidou F., Oulis P., Kelekis N., et al. (2013). A magnetic resonance imaging study of hippocampal, amygdala and subgenual prefrontal cortex volumes in major depression subtypes: melancholic versus psychotic depression. J. Affect. Disord. 146, 197–204. doi:10.1016/j.jad.2012.09.003
37. Vithlani, M., Hines R. M., Zhong P., Terunuma M., Hines D. J., Revilla-Sanchez R., etal. (2013). The ability of BDNF to modify neurogenesis and depressive-like behaviors is dependent upon phosphorylation of tyrosine residues 365/367 in the GABA(A)-receptor γ2 subunit. J. Neurosci. 33, 15567–15577. doi:10.1523/JNEUROSCI.1845-13.2013
38. Wernig, M., Zhao J. P., Pruszak J., Hedlund E., Fu D., Soldner F., et al. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc. Natl. Acad. Sci. U.S.A. 105, 5856–5861. doi:10.1073/pnas.0801677105
39. Yagi, T., Ito D., Okada Y., Akamatsu W., Nihei Y., Okano H., et al. (2012). Modeling familial Alzheimer’s disease with induced pluripotent stem cells. Rinsho Shinkeigaku 52, 1134–1136. doi:10.5692/clinicalneurol.52.1134
40. Yu, J., Chau K. F., Vodyanik M. A., Jiang J., and Jiang Y. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE 6:e17557. doi:10.1371/journal.pone.0017557